Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

AI-Assisted Endoscopy for Upper Aerodigestive Tract Lesions (H&NANCE)

12. května 2026 aktualizováno: Istituto Italiano di Tecnologia

Head&Neck Application of Novel Computer-assisted Endoscopy

This is a prospective observational clinical study designed to evaluate the performance of artificial intelligence (AI) algorithms applied to upper aerodigestive tract (UADT) video-endoscopy. The study assesses three main tasks: lesion detection (localization), classification (benign vs malignant), and segmentation of tumor margins.

AI algorithms will be applied to endoscopic video data acquired during routine clinical practice without influencing clinical decision-making. The system will process images in real time and store data for subsequent analysis. AI outputs will be compared with physician assessment and reference standard histopathology to evaluate diagnostic performance.

Přehled studie

Detailní popis

The artificial intelligence algorithms developed will be employed in the analysis of laryngeal lesions for 3 tasks:

  • Task 1: Computer aided diagnosis (CADx): the algorithm provides a differential diagnosis between benign and malignant neoplasms (binary classification) and the exact histology (multiclass classification). During the UADT video-endoscopy in the outpatient clinic, the physician performs the video-endoscopy and selects and captures n.3 WL and n.3 NBI significant frames of the lesion. The AI model records the classification output of the algorithm that the physician cannot access. The predicted pathologic results will be finally displayed as two different classifications along with the probability of each prediction (0% to 100%) as estimated by the AI algorithm: a first binary classification "neoplastic" or "non-neoplastic," and a second multiclass classification with the exact histology. The physician subsequently, based on the endoscopic examination, will write the suspected diagnosis (benign vs. malignant lesion and the actual histology) in the appropriate patient chart. Next, the physician reviews the screenshot taken and makes sure the lesion is visible in every one of them. Retrospectively, an investigator (blinded to the physician's assessment) will review the AI processed frames with the resulting CADx classifications and mark the AI-processed diagnosis in the patient chart. Once biopsied, the final histology of the lesion analyzed by definitive histopathological examination is recorded in the patient chart by the investigator. The investigators will finally compare the two recorded diagnoses (CADx and physician) with the definitive histology.
  • Task 2: Computer aided detection (CADe): the algorithm, through the representation of a rectangle (bounding box), localizes the lesion during the video-endoscopy in the outpatient clinic in real-time. During the UADT video-endoscopy, the physician performs the video-endoscopy as for standard-of-care procedure. In parallel, the AI model processes in real-time the endoscopic video and records the output of the algorithm (which the physician cannot access). The physician captures n.3 WL and n.3 NBI significant frames of the lesion. Moreover, n.3 frames where no lesions are visible are captured as negative controls. Later, the physician reviews the screenshot taken and makes sure to label the frames where the lesion is visible as "positive cases" and the frame where the lesion is not visible as "negative cases". The investigators will finally assess if the lesion was detected by the CADe system to define a "true positive". Similarly, to define a true negative, the CADe system should have not output a bounding box in the majority of the "negative cases" frames.
  • Task 3: Computer aided segmentation (CASe): the algorithm analyzes the neoplasm margins and provides a delineation mask. In the operating room setting, once the lesion to be resected is identified with a 0° telescope, the surgeon captures n.1 WL and n.1 NBI close-up photographs that exemplify the superficial lesion margins. The same procedure is repeated with a 70° optics and other two photographs are acquired. The frames taken are then saved and analyzed by the AI algorithm, which will perform the segmentation task. The surgeon will be blinded to the AI prediction. Later, the surgeon will draw the margins of the lesion according to her/his evaluation of each captured frame. The annotated frame will be saved so that it can be analyzed at a later time. Afterwards, in cases where positive superficial margins are identified by histopathologic examination, the surgeon-designed margins and the AI model ones will be compared to see if there was any difference in the suggested margin.

Typ studie

Pozorovací

Zápis (Odhadovaný)

283

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

Studijní místa

    • Flemish Brabant
      • Leuven, Flemish Brabant, Belgie, 3000
        • UZ Leuven
        • Kontakt:
        • Vrchní vyšetřovatel:
          • Vincent Vander Poorten, MD PhD
    • GE
      • Genova, GE, Itálie, 16131
        • IRCCS Ospedale Policlinico San Martino
        • Kontakt:
          • Francesco Mora, Otorhinolaryngologist and Prof
          • Telefonní číslo: +39 010-5557479
          • E-mail: Francesco.Mora@unige.it
        • Vrchní vyšetřovatel:
          • Francesco Mora, MD PhD
    • Barcelona
      • Barcelona, Barcelona, Španělsko, 08036
        • Hospital Clinic De Barcelona
        • Kontakt:
        • Vrchní vyšetřovatel:
          • Claudio Sampieri, MD PhD

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

  • Dospělý
  • Starší dospělý

Přijímá zdravé dobrovolníky

Ne

Metoda odběru vzorků

Vzorek nepravděpodobnosti

Studijní populace

The sample size for a single-arm, prospective cohort study, where the same group of patients undergoes testing with an AI model and a human physician and then they are compared with the gold standard reference test (biopsy) was calculated based on information from previous studies

Popis

Inclusion Criteria:

  • Age > 18 years
  • Injury originating from the upper aero-digestive tract
  • Recording of the video-endoscopic examination
  • Patient known to undergo a biopsy of the lesion or clinical follow-up for lesion with known biopsy (e.g. laryngeal papillomatosis) or suffering from Reinke's edema (in this pathology, in fact, biopsy is not necessary since the diagnosis is clinical)
  • Or patients undergoing transoral lesion excision

Exclusion Criteria:

  • Submucosal lesion
  • Patients with previous operations on the upper aero-digestive tract
  • Patients with previous radiotherapy of the head and neck district
  • Poor compliance on endoscopic examination
  • Unavailability of CADe/CADx or CASe data logging note

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Negative Predictive Value of the CADx Algorithm for Malignant or Premalignant Upper Aerodigestive Tract Lesions
Časové okno: From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
Negative Predictive Value (NPV) of the computer-aided diagnosis (CADx) algorithm for classifying UADT lesions as malignant/premalignant versus benign/non-neoplastic, using definitive histopathology as the reference standard. The CADx final classification will be based on the majority rule across selected white-light and narrow-band imaging frames. NPV = true negatives / (true negatives + false negatives). The pre-specified performance target is NPV ≥ 90%.
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
Sensitivity of the CADe Algorithm for Localization of Upper Aerodigestive Tract Lesions
Časové okno: At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Sensitivity of the computer-aided detection (CADe) algorithm for localizing UADT lesions with a bounding box. A true positive is defined as localization of the lesion area by a bounding box in the majority of physician-labeled lesion-positive captured frames. Sensitivity = true positives / (true positives + false negatives).
At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Median Intersection Over Union Between CASe Segmentation and Surgeon-Drawn Lesion Margins
Časové okno: At intraoperative pre-resection endoscopy, with assessment performed after image annotation up to 30 days after surgery.
Median overlap between the AI-generated segmentation mask and the lesion margin area drawn by the surgeon on intraoperative endoscopic images. Intersection over Union (IoU) = area of overlap / area of union. Values range from 0 to 1; higher values indicate greater agreement.
At intraoperative pre-resection endoscopy, with assessment performed after image annotation up to 30 days after surgery.
Median Dice Similarity Coefficient Between CASe Segmentation and Surgeon-Drawn Lesion Margins
Časové okno: At intraoperative pre-resection endoscopy, with assessment performed after image annotation up to 30 days after surgery.
Median Dice Similarity Coefficient (DSC) between the AI-generated segmentation mask and the lesion margin area drawn by the surgeon on intraoperative endoscopic images. Dice Similarity Coefficient = 2 × area of overlap / (AI segmented area + surgeon-drawn area). Values range from 0 to 1; higher values indicate greater agreement.
At intraoperative pre-resection endoscopy, with assessment performed after image annotation up to 30 days after surgery.

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
WL-NPV vs. NBI-NPV of CADx classification
Časové okno: From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.

Negative Predictive Value (NPV) of CADx classification calculated using only the three selected white-light frames, compared with definitive histopathology, vs. NPV of CADx classification calculated using only the three selected narrow-band imaging frames, compared with definitive histopathology.

The final AI-result will be calculated based on the majority rule of the 3 WL and 3 NBI frames computed separately.

From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
Clinician-Reported Usability Score for the AI Endoscopy System
Časové okno: Assessed after clinician use of the AI system during study procedures, up to 20 months after study initiation.
Usability of the AI endoscopy system assessed using standardized usability questionnaires administered to clinicians after use of the AI system. Questionnaire scoring will be interpreted according to the selected questionnaire manual, with higher scores indicating greater usability.
Assessed after clinician use of the AI system during study procedures, up to 20 months after study initiation.
Sensitivity, Specificity and Accuracy of CADx histology prediction
Časové okno: From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
Sensitivity, Specificity and Accuracy of the CADx algorithm for histology prediction, compared with definitive histopathology.
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
F1 Score of CADx Classification
Časové okno: From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
F1 score of the CADx classification output compared with definitive histopathology.
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
Area Under the Receiver Operating Characteristic Curve of CADx Classification
Časové okno: From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
AUC of the ROC curve for CADx classification of UADT lesions compared with definitive histopathology.
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
Sensitivity, Specificity and Accuracy of human physician histology prediction
Časové okno: From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
Sensitivity, Specificity an Accuracy of the treating physician's suspected diagnosis compared with definitive histopathology.
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
Specificity of the CADe Algorithm for Localization of Upper Aerodigestive Tract Lesions
Časové okno: At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Proportion of physician-labeled lesion-negative frames/cases in which the CADe algorithm does not output a bounding box in the majority of negative-control frames.
At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Accuracy of the CADe Algorithm for Localization of Upper Aerodigestive Tract Lesions
Časové okno: At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Overall proportion of correctly classified lesion-positive and lesion-negative cases/frames by the CADe algorithm.
At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Positive Predictive Value of the CADe Algorithm for Localization of Upper Aerodigestive Tract Lesions
Časové okno: At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Positive predictive value of CADe bounding-box output for lesion localization. PPV = true positives / (true positives + false positives).
At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Negative Predictive Value of the CADe Algorithm for Localization of Upper Aerodigestive Tract Lesions
Časové okno: At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Negative predictive value of CADe absence of bounding-box output for lesion localization. NPV = true negatives / (true negatives + false negatives).
At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
Percentage of Positive Superficial Margin Cases in Which the AI-Predicted Tumor Area Is Wider Than the Surgeon-Drawn Area
Časové okno: At intraoperative pre-resection endoscopy, with assessment performed after image annotation up to 30 days after surgery.
Among cases with positive superficial margins on final histopathology, percentage of cases in which the AI-predicted tumor area extends beyond the surgeon-drawn margin at the affected margin.
At intraoperative pre-resection endoscopy, with assessment performed after image annotation up to 30 days after surgery.

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Obecné publikace

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

1. května 2026

Primární dokončení (Odhadovaný)

1. prosince 2027

Dokončení studie (Odhadovaný)

1. února 2028

Termíny zápisu do studia

První předloženo

5. května 2026

První předloženo, které splnilo kritéria kontroly kvality

12. května 2026

První zveřejněno (Aktuální)

19. května 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

19. května 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

12. května 2026

Naposledy ověřeno

1. května 2026

Více informací

Termíny související s touto studií

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NEROZHODNÝ

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit